Needham & Company Maintains Bullish View on Sarepta Therapeutic (SRPT) Following Results and Eteplirsen Regulatory Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. XENE
2. HUBS
3. SPY
4. NUE
5. AAPL
6. AZN
7. TRMD
8. RARE
9. RTB
10. INTU

Go back to Needham & Company Maintains Bullish View on Sarepta Therapeutic (SRPT) Following Results and Eteplirsen Regulatory Update
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 20.61 -0.06 (0.29%)
Previous Close $20.67    52 Week High $63.73 
Open $20.63    52 Week Low $8.00 
Day High $20.74    P/E N/A 
Day Low $20.40    EPS $-5.69 
Volume 132,019